Showing 182 results
- https://www.novartis.com/news/novartis-completes-safety-review-and-initiates-update-beovu-prescribing-information-worldwide
- https://www.novartis.com/news/novartis-condemns-war-ukraine-and-commits-supporting-humanitarian-efforts
- https://www.novartis.com/news/novartis-expands-humanitarian-efforts-ukraine-through-donation-essential-medicines
- https://www.novartis.com/news/novartis-announces-first-european-donation-hydroxychloroquine-switzerland
- https://www.novartis.com/news/novartis-medikidz-and-copd-foundation-partnership-superhero-proportions
We teamed up with Medikidz and the COPD Foundation to develop a creative way to explain COPD to children.
- https://www.novartis.com/news/innovation-practice-how-we-form-partnerships-pharma
The Novartis Business Development and Licensing team is behind many of the partnerships that fuel our innovation.
- https://www.novartis.com/news/novartis-evolving-business-practices-better-educate-medical-community
Seeking to evolve the way it educates and engages with healthcare professionals, Novartis is using digital technology to enhance the quality, transparency and reach of its interactions with the medical community.
- https://www.novartis.com/news/medical-researchers-using-new-tools-turn-science-fiction-science-fact
Jay Bradner, President of the Novartis Institutes for BioMedical Research (NIBR) and Vas Narasimhan, Head of Global Drug Development and Chief Medical Officer, share their outlook for innovation in 2017.
- https://www.novartis.com/news/students-take-challenges-digital-medicine
Novartis BioCamp gives students new perspectives on healthcare challenges.
- https://www.novartis.com/news/solar-1-nejm-publication